UK’s Ambitious Plan For Medtech Regulation Merits Attention

MHRA aims for balance in future system consultation

The MHRA’s efforts to give the UK a nimble, responsive, innovation-facing medtech regulatory system earnt high marks from Bristows’ Alex Denoon, who assessed the opportunity at hand during the MedTech Summit.

Union_Jack

The Medicines and Healthcare products Regulatory Agency (MHRA) consultation on the role and shape of the UK’s post-Brexit medical devices regulatory landscape is exactly halfway through the 10 weeks given. In a perfect world, the responses would be graded, analyzed and factored into legislation that is scheduled for release as a draft instrument in April 2022.

That would give 15 months for the legislation to get through parliament, be put in place and working at full...

More from United Kingdom

More from Europe